Cell Therapy Clinical Trials retweeted
Cell Therapy Clinical Trials retweeted
I am thrilled to announce that my latest research article has been published: This study demonstrates for the first time that hMSCs transduced with lentiviral vectors can be successfully expanded in agitated conditions using microcarriers.
link.springer.com/article/10…
I am thrilled to announce that my latest research article has been published: This study demonstrates for the first time that hMSCs transduced with lentiviral vectors can be successfully expanded in agitated conditions using microcarriers.
link.springer.com/article/10…
Cell Therapy Clinical Trials retweeted
Ever wondered what happened to #celltherapies for #COVID19???
🤔🤔🤔
Check out this comprehensive study initiated by Fran & Pedro
👏👏👏
@celltrialsdata @ISCTglobal @AgenciaFAPESP @ChariteBerlin @berlinnovation @Yale @ucl @MesenchymalCell #SARSCoV2
👇👇👇
frontiersin.org/articles/10.…
What happened in the Cell and Gene Therapy sector last week! (Thread) (1/9)
cgtnewsletter.substack.com/p…
(9/9) Non-Viral CAR-T Clinical Trial - Virus-free CAR-T cell product (PD1-19bbz) was evaluated in a clinical trial for adults with relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL) showing CR= 86%, PFS of 19.5 months.
ncbi.nlm.nih.gov/pmc/article…
(8/9) CAR-T Cost Analysis Evaluation - Study focused on evaluating the cost-effectiveness of CAR-T treatments as a second line of treatment for diffuse large B-cell lymphoma shows that it's a cost-effective option in the US but not in China.
ncbi.nlm.nih.gov/pmc/article…
(7/9) Next Generation CAR Products - Study focused on designing a next-generation CAR-NK product to target triple-negative breast cancer (TNBC), demonstrated cytotoxicity in vitro using a 3D tumor model.
ncbi.nlm.nih.gov/pmc/article…
(6/9) Bristol Myers Squibb (BMS) is expanding its manufacturing capabilities by taking over a Novartis plant in Libertyville, Illinois.
fiercepharma.com/manufacturi…
(5/9) Janssen Biotech to pay $245M to Cellular Biomedicine Group (CBMG) to develop next-generation CAR-T therapies for diffuse large B-cell lymphoma (DLBCL).
biospace.com/article/j-and-j…
(4/9) Ossium Health secures $3.46M funding from California Institute for Regenerative Medicine (CIRM) to accelerate the development of OSSM-007, a promising treatment for steroid-refractory acute graft versus host disease (GvHD).
businesswire.com/news/home/2…
(3/9) NanoFCM Co., Ltd, and RoosterBio to initiate a partnership to advance workflows in extracellular vesicle analytics.
prweb.com/releases/nanofcm_p…
(2/9) Direct Biologics receives FDA clearance for a clinical trial of ExoFlo™ in perianal fistulizing Crohn’s disease (news here). ExoFlo™ is an extracellular vesicle (EV) product using BM-hMSCs as a producer cell line (BM-hMSCs).
businesswire.com/news/home/2…
Cell Therapy Clinical Trials retweeted
📢 Publication alert! 🔥 study on #AAV gene therapy for Niemann-Pick type C. Great work team 👏🏼👏🏼👏🏼 #LysosomalDiseases #GeneTherapy
Out now - publication identifying novel short NPC1 promoter enhancing #GeneTherapy for Niemann-Pick type C Disease 👇 mdpi.com/2073-4409/12/12/161… @Cells_MDPI @The_MRC @NiemannPickUK @nnpdf @inpda_org @DrMichaelHughes @HemanthNelvagal @DrGiuliaMassaro @UCL_Business @UCLTF @UCLTRO
Cell Therapy Clinical Trials retweeted
This is quite a deal for Quell with @AstraZeneca (& for cell therapy in general).
2B or nor 2B!
Amazing news for Quell Therapeutics.
Major collaboration that is a huge plus for cell therapy industry in the UK
quell-tx.com/quell-therapeut…
Cell Therapy Clinical Trials retweeted
This is the reality of running a small restaurant in Britain right now. It’s a miracle we survive | Mandy Yin @SambalShiok
My wife's piece in the @guardian 👇, the harsh reality for many independent business owners. theguardian.com/commentisfre…
Cell Therapy Clinical Trials retweeted
If you haven't done so already. Sign up for this newsletter 👇, great to keep up to do date on all things going on within the fast moving cell & gene therapy space.
Breakdown of latest business developments and research. Pass it on
Stay informed and read the full issue at: cgtnewsletter.substack.com/p…
Intracranial injection of HER2-targeted CAR-NK dosed between 10 and 100 million cells is safe but fails to demonstrate clinical efficacy in patients with recurrent glioblastoma shows phase 1 clinical trial (N=9).
(8/8).
pubmed.ncbi.nlm.nih.gov/3714…












